Impact of Bright Light Therapy on Prader-Willi Syndrome

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Prader-Willi Syndrome, Excessive Daytime Sleepiness, Hyperphagia, Body Weight, Mood, Behavior

In brief

This is a placebo controlled clinical trial to assess the utility of light therapy as a sufficient treatment for excessive daytime sleepiness in patients with Prader-Willi Syndrome

Key facts

Study ID

NCT05939453

Run by

Maimonides Medical Center

People needed

50

Starts

2023-10-01

Expected to finish

2026-12-01

Last updated by the study team

2026-05-15

Who can join

Age: 6 and older, up to 88. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of PWS confirmed by genetic testing
• Score of 12 or above on the Epworth Sleepiness Scale (ESS).

You may not qualify if…

• Subjects with an eye condition that could be negatively affected by bright light such as patients with a history of retinal damage or patients needing photosensitizing medications
• A history of previous treatment with LT
• Patients presenting with active psychosis or mania

Where it is running

• Maimonides Medical Center — Brooklyn, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.